Apr 13, 2026
Revolution Medicines (RVMD) Stock Jumps 38% Following Breakthrough Pancreatic Cancer Data
Revolution Medicines (RVMD) stock surged 38% after Phase 3 data showed daraxonrasib achieved 13.2 months survival vs. 6.7 months with chemotherapy.
The post Revolution Medicines (RVMD) Stock Jumps 38% Following Breakthrough Pancreatic Cancer Data appeared first on Blockonomi.
Source: Blockonomi →Related News
- 8 hours ago
Apple (AAPL) Stock: Q2 Earnings Beat Expectations with 17% Revenue Jump and $100...
- 11 hours ago
Alphabet (GOOGL) Stock Soars 10% as Q1 Results Demolish Analyst Projections
- 11 hours ago
Amazon (AMZN) Stock Dips After Strong Q1 Earnings — What Spooked Investors?
- 11 hours ago
CoreWeave (CRWV) Stock Climbs 8% Despite $45M Insider Share Dump
- 12 hours ago
Nvidia (NVDA) Tumbles 4% Amid Rising Competition from Google and Amazon Custom C...